Business Context and Reporting Period
This Form 8-K was filed by Houlihan Lokey, Inc. on February 10, 2017, reporting events occurring on February 6 and February 8, 2017. The filing details a secondary public offering of Class A common stock and a concurrent forward share purchase agreement.
Key Financial Metrics and Transaction Details
- Offering Size: 8,000,000 shares of Class A common stock.
- Offering Price: $29.25 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 1,200,000 additional shares.
- Proceeds to Company: The Company will not receive net proceeds from the sale of shares by the Selling Stockholders (former and current employees and management).
- Forward Purchase Agreement: The Company agreed to repurchase Class B common stock from an ORIX USA subsidiary on April 5, 2017, equal to the number of Class A shares sold in the offering.
- Repurchase Price: Public offering price less underwriting discounts and commissions.
Material Changes and Transaction Structure
The primary material event is the execution of an underwriting agreement with Merrill Lynch, Goldman Sachs, and J.P. Morgan. While the Company is not receiving proceeds from the selling stockholders, it is utilizing net proceeds from the offering to fund the repurchase of Class B shares from ORIX USA. This structure effectively converts Class B shares held by ORIX into Class A shares sold to the public, with the Company acting as an intermediary for the capital flow related to the repurchase.
Outlook, Risks, and Contingencies
- Closing Date: The offering is expected to close on or about February 14, 2017, subject to customary conditions.
- Dividend Adjustment: If a dividend is paid between the offering closing and the April 5, 2017 settlement of the purchase agreement, the repurchase price will be reduced by the per-share dividend amount.
- Forward-Looking Statements: The filing contains forward-looking statements regarding the transaction completion and future performance, which are subject to risks and uncertainties.
Key Facts for Investor Verification
- Verify the final number of shares sold, including any exercise of the 1,200,000 share over-allotment option.
- Confirm the actual closing date of the offering and the settlement of the Forward Share Purchase Agreement on April 5, 2017.
- Review the impact of the transaction on the Company's capital structure and the reduction of Class B shares held by ORIX USA.
- Check for any dividends declared between the offering closing and the April 2017 settlement date that would affect the repurchase price.